Cancers of the liver, bile ducts, gallbladder, and pancreas—collectively known as hepatobiliary and pancreatic cancers—are among the most complex and aggressive forms of cancer. What makes them particularly challenging is that they often go undetected until the disease has progressed to an advanced stage. By this time, treatment options may be limited, and the chances of long-term survival significantly decrease. Early detection, therefore, plays a crucial role in improving outcomes, expanding treatment possibilities, and enhancing quality of life for patients.
